SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-115097
Filing Date
2020-10-15
Accepted
2020-10-15 07:00:42
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcli-20200930x10q.htm   iXBRL 10-Q 1121221
2 EXHIBIT 31.1 bcli-20200930xex31d1.htm EX-31.1 10808
3 EXHIBIT 31.2 bcli-20200930xex31d2.htm EX-31.2 10669
4 EXHIBIT 32.1 bcli-20200930xex32d1.htm EX-32.1 7516
5 EXHIBIT 32.2 bcli-20200930xex32d2.htm EX-32.2 7517
  Complete submission text file 0001104659-20-115097.txt   3635564

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcli-20200930.xsd EX-101.SCH 28310
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcli-20200930_cal.xml EX-101.CAL 27782
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcli-20200930_def.xml EX-101.DEF 81527
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcli-20200930_lab.xml EX-101.LAB 220674
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcli-20200930_pre.xml EX-101.PRE 182017
11 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20200930x10q_htm.xml XML 459878
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 201240292
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences